Jove
Visualize
Contact Us

Related Experiment Videos

Dexmedetomidine for neurological surgery.

Alex Bekker1, Mary K Sturaitis

  • 1Department of Anesthesiology, New York University Medical Center, New York, New York, USA.

Neurosurgery
|July 1, 2005
PubMed
Summary

Dexmedetomidine, an alpha2-adrenergic agonist, provides cooperative sedation, anxiolysis, and analgesia without respiratory depression. Its neuroprotective and hemodynamic stabilizing effects are valuable in neuroanesthesia and neurocritical care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TET1 downregulation in the dorsal root ganglion and spinal cord is required for short-term sleep disturbance to delay surgical pain recovery.

British journal of anaesthesia·2026
Same author

Contribution of proneurotrophin-3 to nerve trauma-induced neuropathic pain through promoting TrkC-mediated increase of CCL2 in primary sensory neurons.

Brain, behavior, and immunity·2026
Same author

Proneurotrophin-3 contributes to chemotherapy-induced neuropathic pain through TrkC-mediated CCL2 elevation in DRG neurons.

EMBO reports·2025
Same author

Withdrawal Note: NT-3 contributes to chemotherapy-induced neuropathic pain through TrkC-mediated CCL2 elevation in DRG neurons.

EMBO reports·2025
Same author

STIM1 functionally couples to transient receptor potential ankyrin 1 contributing to nociception.

Pain·2025
Same author

RNA-binding protein SYNCRIP contributes to neuropathic pain through stabilising CCR2 expression in primary sensory neurones.

British journal of anaesthesia·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neuroscience
  • Pharmacology
  • Critical Care Medicine

Background:

  • Dexmedetomidine is an emerging intravenous agent.
  • It is increasingly utilized in neuroanesthesia and neurocritical care.
  • Alpha2-adrenergic agonists possess unique sedative and analgesic properties.

Purpose of the Study:

  • To review the neuropharmacology and neurophysiology of alpha2-adrenergic agonists.
  • To examine the application of dexmedetomidine in neurosurgical case management.

Main Methods:

  • Literature review of neuropharmacology and neurophysiology.
  • Analysis of dexmedetomidine's clinical applications in neurosurgery.

Main Results:

  • Dexmedetomidine offers "cooperative sedation," anxiolysis, and analgesia.

Related Experiment Videos

  • It lacks respiratory depression and exhibits neuroprotective effects.
  • Sympatholytic and antinociceptive actions ensure hemodynamic stability during neurosurgical stimulation.

    • Conclusions:

    • Dexmedetomidine presents a favorable neurophysiological profile.
    • Its properties support its use as an adjuvant in neurosurgical procedures.
    • Further research into its evolving applications is warranted.